The extracellular matrix is the structural substance that surrounds cells in nearly all tissues in the body. The composition of the extracellular matrix varies by the type of tissue, it is generally composed of four major types of molecules, namely, Structural proteins, glycoproteins, glycosaminoglycan’s, and proteoglycans. Structural proteins, such as collagen and elastin, provide the main structural framework in extracellular matrix. Glycoproteins help bind cells to the collagen. Glycosaminoglycans and proteoglycans keep the matrix well hydrated by absorbing water and binding growth factors.
Rising adoption of extracellular matrix in hernia and pelvic reconstruction surgeries, increasing focus of major players towards development of extracellular matrix, and technological advancements in extracellular matrix are some of the factors estimated to stimulate the growth of the market over the forecast period.
The report segments the extracellular matrix (ECM) patches market based on raw material type, applications, and regions. In terms of raw material, the market is divided into bovine ECM patches, porcine ECM patches, and other ECM patches. On the basis of applications, the market is classified into cardiac repair, vascular repair & reconstruction, pericardial repair, dural repair, soft tissue repair, and wound healing.
This report is a comprehensive study of current trends in the market, industry growth drivers, and restraints. These markets are given analysis at regional level to provide exhaustive value market analysis for the years 2016, 2017, 2018, and forecast to 2023. Each market is comprehensively analyzed at a granular level by region (North America, Europe, Asia-Pacific, and RoW) to provide in-depth information on the global scenario.
The key players in the global extracellular matrix market are Smith & Nephew, Boston Scientific Corporation, Koninklijke DSM N.V., Coloplast Group, Cook Group, MTF Biologics, Medtronic, Baxter, Aziyo Biologics, and Admedus Ltd.
Table of Contents
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.6 Market Stakeholders
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Extracellular Matrix (ECM) Patches Market, By Raw Material Type
6.2 Bovine ECM Patches
6.3 Porcine ECM Patches
6.4 Other ECM Patches
7 Extracellular Matrix (ECM) Patches Market, By Applications
7.2 Cardiac Repair
7.3 Vascular Repair & Reconstruction
7.4 Pericardial Repair
7.5 Dural Repair
7.6 Wound Healing
7.7 Soft Tissue Repair
8 Extracellular Matrix (ECM) Patches Market, By Region
8.2 North America
9 Competitive Landscape
9.2 Key Player Ranking Analysis (2017)
9.3 Competitive Scenario
10.3.1 Agreements, Partnerships, Collaborations, and Contracts
10.3.4 Product Launches
10 Company Profiles (Overview, Products and Services, Financials, Strategies & Developments)
10.2 Cook Group
10.3 Coloplast Group
10.4 Smith & Nephew
10.5 Koninklijke Dsm N.V.
10.6 Mtf Biologics
10.7 Boston Scientific Corporation
10.10 Aziyo Biologics
10.11 Admedus Ltd.
The Segmentation Given May Change Depending on Research Findings.
The List of Companies May Change as Per Further Research Findings. Top 10 Companies Will Be Profiled in This Section. Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies
Years Considered for the Study Would Be Historical Year – 2016, Base Year – 2017, Estimated Year – 2018, Forecast Period – 2018 to 2023
The Market Tables Would Include Value Data in USD for the Years 2016, 2017, 2018 and Forecasted Value for 2023 Along With CAGR for the Period 2018-2023
Benchmarking the rapid strategy shifts of the Top 100 companies in the Extracellular Matrix (ECM) Patches MarketRequest For Special Pricing